NAFLD - NON-ALCOHOLIC FATTY LIVER DISEASE
Clinical trials for NAFLD - NON-ALCOHOLIC FATTY LIVER DISEASE explained in plain language.
Never miss a new study
Get alerted when new NAFLD - NON-ALCOHOLIC FATTY LIVER DISEASE trials appear
Sign up with your email to follow new studies for NAFLD - NON-ALCOHOLIC FATTY LIVER DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill aims to shrink dangerous liver fat
Disease control Recruiting nowThis study is testing a new oral medication called HP515 to see if it can safely reduce the amount of fat in the liver of people with non-alcoholic fatty liver disease (NAFLD). About 80 participants will take either the HP515 tablet or a placebo (a dummy pill) for 12 weeks. Resea…
Matched conditions: NAFLD - NON-ALCOHOLIC FATTY LIVER DISEASE
Phase: PHASE2 • Sponsor: Hinova Pharmaceuticals Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
Could a simple scan replace the needle for liver disease?
Diagnosis Recruiting nowThis study is testing a new ultrasound method to measure fat in the liver. It aims to provide a simpler, non-invasive way to detect and monitor fatty liver disease (MASLD) compared to current methods like MRI or biopsy. Researchers will compare the new ultrasound tool's results a…
Matched conditions: NAFLD - NON-ALCOHOLIC FATTY LIVER DISEASE
Phase: NA • Sponsor: ContextVision AB • Aim: Diagnosis
Last updated Mar 12, 2026 13:51 UTC